Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
- Status
- COMPLETED
- Phase
- NA
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Status
- RECRUITING
- Phase
- NA
Inqovi Maintenance Therapy in Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)
- Status
- COMPLETED
- Phase
- N/A
Physical Activity in Transfusion Dependent Patients With Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- N/A
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
- Status
- WITHDRAWN
- Phase
- NA
Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
- Status
- UNKNOWN
- Phase
- PHASE2